Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Immunogen, inc. crawled time : 00:20 save search
MIRASOL: A Randomized, Open-Label, Phase 3 Study of Mirvetuximab Soravtansine vs Investigator’s Choice of Chemotherapy in Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers with High Folate Receptor Alpha Expression
Published: 2022-03-19 (Crawled : 00:20) - immunogen.com
IMGN | News | $31.23 0.03% 49M
|
Health Technology
| Email alert
Add to watchlist
label one therapy cancer mirvetuximab phase 3
PICCOLO: A Phase 2, Single Arm Study of Mirvetuximab Soravtansine in Recurrent, Platinum-Sensitive, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers with High Folate Receptor Alpha Expression
Published: 2022-03-19 (Crawled : 00:20) - immunogen.com
IMGN | News | $31.23 0.03% 49M
|
Health Technology
| Email alert
Add to watchlist
phase 2 one cancer mirvetuximab
Mirvetuximab Soravtansine, a Folate Receptor Alpha Targeting Antibody-Drug Conjugate, in Combination with Bevacizumab in Patients with Platinum-Agnostic Ovarian Cancer: Final Analysis
Published: 2022-03-19 (Crawled : 00:20) - immunogen.com
IMGN | News | $31.23 0.03% 49M
|
Health Technology
| Email alert
Add to watchlist
drug ovarian cancer cancer mirvetuximab antibody
Efficacy and Safety of Mirvetuximab Soravtansine in Patients with Platinum-Resistant Ovarian Cancer with High Folate Receptor Alpha Expression: Results from the SORAYA Study
Published: 2022-03-19 (Crawled : 00:20) - immunogen.com
IMGN | News | $31.23 0.03% 49M
|
Health Technology
| Email alert
Add to watchlist
ovarian cancer results cancer mirvetuximab
ImmunoGen Announces Webcast of Presentation and Q&A at Upcoming SVB Leerink 11th Annual Global Healthcare Conference
Published: 2022-02-04 (Crawled : 00:20) - biospace.com/
IMGN | News | $31.23 0.03% 49M
|
Health Technology
|
| O: 1.55%
H: 0.0%
C: 0.0%
health ces thc conference presentation
Gainers vs Losers
| 49% | 51% |
Top 10 Gainers
TRMK 4 | $29.89 1.81% 2.7K
|
Finance
TSHA | $2.375 1.06% 19K
|
Health Technology
TSN | $61.57 0.41% 14K
|
Consumer Non-Durables
TMUS S | $164.61 0.26% 190K
|
Communications
TTEC 4 | $8.02 1.5K
|
Commercial Services
TRMB S | $59.26 -0.42% 9.8K
|
Electronic Technology
AMED | $90.65 -0.44% 3.1K
|
Health Services
TRV | $211.8 -0.76% 21K
|
Finance
TRS 4 | $26.08 -0.76% 1K
|
Producer Manufacturing
TT | $294.15 -0.79% 21K
|
Producer Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.